Showing 441-450 of 4005 results for "".
Maximizing Weight Loss & Minimizing Side Effects With GLP-1
https://reachmd.com/programs/diabetes-discourse/maximizing-weight-loss-minimizing-side-effects-with-glp-1/15149/Get the latest insights from an expert in the field on how to counsel your patients to maximize weight loss with GLP-1 receptor agonists.HER2-Targeted TKI Combinations in Second-Line and Beyond MBC
https://reachmd.com/programs/cme/her2-targeted-tki-combinations-in-second-line-and-beyond-mbc/29945/What’s the latest on managing HER2-expressing MBC with brain metastasis? Join our experts and learn about the most recent treatment strategies.Differentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer
https://reachmd.com/programs/cme/differentiating-agents-in-the-expanding-her2-targeted-arsenal-for-metastatic-breast-cancer/29944/What’s the latest on managing HER2-expressing MBC with brain metastasis? Join our experts and learn about the most recent treatment strategies.Navigating the Therapeutic Landscape for IBD
https://reachmd.com/programs/gi-insights/navigating-the-therapeutic-landscape-for-ibd/13941/What medications are currently available for patients with IBD, and how do we know which ones are right for our patients? Get the latest updates.Applying Data Into Practice: Sequencing Strategies for HER2-Targeted Breast Cancer
https://reachmd.com/programs/cme/applying-data-into-practice-sequencing-strategies-for-her2-targeted-breast-cancer/29953/What’s the latest on managing HER2-expressing MBC with brain metastasis? Join our experts and learn about the most recent treatment strategies.Leveraging Clinical Data: HER2-Targeted ADCs in Second-Line and Beyond MBC
https://reachmd.com/programs/cme/leveraging-clinical-data-her2-targeted-adcs-in-second-line-and-beyond-mbc/29946/What’s the latest on managing HER2-expressing MBC with brain metastasis? Join our experts and learn about the most recent treatment strategies.Recent Updates in HER2-Targeted TKIs for Metastatic Breast Cancer
https://reachmd.com/programs/cme/recent-updates-in-her2-targeted-tkis-for-metastatic-breast-cancer/29951/What’s the latest on managing HER2-expressing MBC with brain metastasis? Join our experts and learn about the most recent treatment strategies.Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches
https://reachmd.com/programs/cme/systemic-management-of-brain-metastases-in-her2-bc-emerging-strategies-and-treatment-approaches/29949/What’s the latest on managing HER2-expressing MBC with brain metastasis? Join our experts and learn about the most recent treatment strategies.Bridging the Gap in AYA Cure Rates
https://reachmd.com/programs/medical-industry-feature/bridging-the-gap-in-aya-cure-rates/35630/Explore the latest data on asparaginase-based therapies for adolescents and young adults with acute lymphoblastic leukemia and lymphoblastic lymphoma. For US HCPs Only.Understanding CNS Lesions in HER2+ Metastatic Breast Cancer
https://reachmd.com/programs/cme/understanding-cns-lesions-in-her2-metastatic-breast-cancer/29948/What’s the latest on managing HER2-expressing MBC with brain metastasis? Join our experts and learn about the most recent treatment strategies.